Executive Director, Venture Development and the Technology Incubation Program (TIP) University of Connecticut
Mostafa Analoui, Ph.D., is executive director of venture development and the Technology Incubation Program (TIP) at the University of Connecticut. Previously, he was head of healthcare and life sciences at Livingston Securities, with investment focus in private and public companies in biotech, medtech and healthcare services. Prior to that, he was the senior director at Pfizer Global Research and Development. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging and global strategies.
At Pfizer, he was the site head for global clinical technology in Groton and New London, focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Analoui was the director of Oral and Maxillofacial Imaging Research, associate professor of radiology at Indiana University, and associate professor of biomedical engineering and electrical & computer engineering at Purdue University. He was also president and CEO of Therametric Technology Inc. He received his Ph.D. from Purdue University, followed by a postdoctoral fellowship at IBM T. J. Watson Research Center in New York.
Analoui consults and lectures in the United States, Europe and Asia. He has also served on various scientific, regulatory and business advisory committees and boards, including the National Institutes of Health, the National Science Foundation, Pharmaceutical Researchers and Manufacturers of America, the National Aeronautics and Space Administration, and the Organisation for Economic Co-operation and Development. Analoui has authored over 130 publications. Analoui is currently an adjunct professor at Brown University, Northeastern University and the University of Connecticut. He is also a senior member of the Institute of Electrical and Electronics Engineers, SPIE—the International Society for Optical Engineering, and the Radiological Society of North America.
He was board chairman for VirtualScopics and currently serves on the boards of Cyclica, Biomedical Engineering Alliance and Consortium, and NanoBusiness Commercialization Association.